Trilantic North America Congratulates Rarebreed Veterinary Partners’ Daniel Espinal and Sean Miller on their Recognition as EY Entrepreneurs of the Year New England 2021
Trilantic North America is pleased to congratulate Rarebreed Veterinary Partners Co-Founders Daniel Espinal, CEO, and Sean Miller, COO for their recognition on EY’s Entrepreneur of the Year® New England 2021 list. In its 35th year, this award honors entrepreneurial creators and disrupters in the New England Region.
This group of entrepreneurial leaders was selected by an independent judging panel made up of previous award winners, leading CEOs, investors and other regional business leaders. Both Dan and Sean were chosen based on their strong leadership and entrepreneurial skills, and ambition to drive Rarebreed forward in the fast-growing veterinary care space. Since beginning its partnership with Rarebreed in 2020, Trilantic North America is proud to partner with Dan, Sean, and the rest of the Rarebreed team to continue driving the company’s growth and evolution.
To learn more about the award selection process and view the full list of 2021 winners, please visit the link below.
Jul 30, 2021
Trilantic Capital Management L.P. (“Trilantic North America”) is a leading, growth-focused middle market private equity firm focused on control and significant minority investments in North America. Trilantic North America’s primary investment focus is in the business services, consumer and energy sectors. Trilantic North America has managed six private equity funds families with aggregate capital commitments of $9.7 billion. Trilantic North America has been recognized by Inc. Magazine’s 2019 list of Top 50 Founder-Friendly Private Equity Firms.
For more information, visit www.trilanticnorthamerica.com.
Trilantic North America
Rarebreed Veterinary Partners is a thriving community of veterinary hospitals in the Northeast that values healthcare teams and provides superior medical and compassionate care to pets. Rarebreed creates exceptional work experiences, one partnership at a time, and believes when healthcare teams thrive, economic and emotional wellbeing prosper. As a result, clients and pets receive the veterinary experience they expect and deserve. The Rarebreed goal is to become the employer of choice for those dedicating their professional lives to veterinary care. Rarebreed accomplishes this through innovation and industry-leading benefits, including equity buy-in, outsized parental leave, pet medical benefits, and best-in-class healthcare benefits. Rarebreed invests in business operations and a technology backend that provides deep analytics into practices.
Rarebreed Veterinary Partners